Related Experiment Videos
Early primary valve ablation for posterior urethral valves
1Division of Pediatric Urology, University of Washington School of Medicine, Children's Hospital and Medical Center, Seattle 98105, USA.
Seminars in Pediatric Surgery
|February 1, 1996
Summary
Early valve ablation (EVA) improves survival for infant boys with posterior urethral valves. This treatment allows damaged bladders and upper tracts to heal, maximizing urinary tract function.
Area of Science:
- Pediatric Urology
- Endourology
- Nephrology
Background:
- Posterior urethral valves (PUV) cause urethral obstruction, leading to urinary tract abnormalities.
- Improved survival in infant boys with PUV is noted due to early diagnosis and advanced endoscopic techniques.
Observation:
- Sequelae of PUV include damage to the urethra, bladder, ureters, and kidneys.
- Early valve ablation (EVA) allows the bladder and upper tracts to potentially heal post-obstruction.
- Patients undergoing EVA show improved bladder capacity, compliance, and reflux resolution within a year.
Findings:
- Renal insufficiency in PUV patients is often due to primary renal dysplasia, leading to potential renal failure.
- Upper tract diversion has not improved long-term outcomes in renal dysplasia and can impair bladder healing.
- EVA is suggested as the definitive treatment for PUV, even in cases of renal insufficiency.
Implications:
- EVA maximizes the potential for urinary tract healing and function in infants with posterior urethral valves.
- Preserving bladder function through EVA is crucial for long-term outcomes.
- Early primary ablation is recommended over upper tract diversion for managing posterior urethral valves.